Steven Cohen's FENC Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 56,407 shares of Fennec Pharmaceuticals Inc. (FENC) worth $606,375, representing 0.00% of the portfolio. First purchased in 2023-Q1, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in FENC for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 56,407 shares. Largest reduction occurred in Q1 2026, reducing 21,298 shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Fennec Pharmaceuticals (FENC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Fennec Pharmaceuticals (FENC) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +56,407 | New Buy | 56,407 | $10.75 |
| Q1 2026 | -21,298 | Sold Out | 0 | $0.00 |
| Q4 2025 | +21,298 | New Buy | 21,298 | $7.70 |
| Q2 2023 | -3,100 | Sold Out | 0 | $0.00 |
| Q1 2023 | +3,100 | New Buy | 3,100 | $8.32 |
Steven Cohen's Fennec Pharmaceuticals Investment FAQs
Steven Cohen first purchased Fennec Pharmaceuticals Inc. (FENC) in Q1 2023, acquiring 3,100 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Fennec Pharmaceuticals Inc. (FENC) for 5 quarters since Q1 2023.
Steven Cohen's largest addition to Fennec Pharmaceuticals Inc. (FENC) was in Q2 2026, adding 56,407 shares worth $606,375.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 56,407 shares of Fennec Pharmaceuticals Inc. (FENC), valued at approximately $606,375.
As of the Q2 2026 filing, Fennec Pharmaceuticals Inc. (FENC) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Fennec Pharmaceuticals Inc. (FENC) was 56,407 shares, as reported at the end of Q2 2026.